References
- Davies BM, Mowforth OD, Smith EK, Kotter MR. Degenerative cervical myelopathy. BMJ 2018;360:k186.
- Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis. Spine (Phila Pa 1976) 2015;40:E675–693.
- Grodzinski B, Durham R, Mowforth O, Stubbs D, Kotter MRN, Davies BM. The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic review. Age Ageing 2020;50:705–715.
- Davies BM, Mowforth O, Gharooni A-A, et al. A new framework for investigating the biological basis of degenerative cervical myelopathy [AO spine RECODE-DCM research priority number 5]: mechanical stress, vulnerability and time. Global Spine J 2022;12:78S–96S.
- Kovalova I, Kerkovsky M, Kadanka Z, et al. Prevalence and imaging characteristics of nonmyelopathic and myelopathic spondylotic cervical cord compression. Spine (Phila Pa 1976) 2016;41:1908–16.
- Smith SS, Stewart ME, Davies BM, Kotter MRN. The prevalence of asymptomatic and symptomatic spinal cord compression on magnetic resonance imaging: a systematic review and meta-analysis. Global Spine J 2021;11:597–607.
- Oh T, Lafage R, Lafage V, et al. Comparing quality of life in cervical spondylotic myelopathy with other chronic debilitating diseases using the SF-36 survey. World Neurosurg 2017;106:699–706.
- Hirayama Y, Mowforth OD, Davies BM, Kotter MRN. Determinants of quality of life in degenerative cervical myelopathy: a systematic review. Br J Neurosurg 2021;18:1–11.
- Mowforth OD, Davies BM, Kotter MR. Quality of life among informal caregivers of patients with degenerative cervical myelopathy: cross-sectional questionnaire study. Interact J Med Res 2019;8:e12381.
- Davies B, Mowforth O, Sadler I, et al. Recovery priorities in degenerative cervical myelopathy: a cross-sectional survey of an international, online community of patients. BMJ Open 2019;9:e031486.
- Boerger T, Alsouhibani A, Mowforth O, et al. Moving beyond the neck and arm: the pain experience of people with degenerative cervical myelopathy who have pain. Global Spine J 2021;25:219256822098614.
- Fehlings MG, Wilson JR, Kopjar B, et al. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am 2013;95:1651–8.
- Fehlings MG, Ibrahim A, Tetreault L, et al. A global perspective on the outcomes of surgical decompression in patients with cervical spondylotic myelopathy: results from the prospective multicenter AOSpine international study on 479 patients. Spine (Phila Pa 1976) 2015;40:1322–8. Sep 1,
- Davies BM, Mowforth O, Wood H, et al. Improving awareness could transform outcomes in Degenerative Cervical Myelopathy (DCM) [AO Spine RECODE DCM Research Priority Number 1]. Glob Spine J 2022;12:28S–38S.
- Khan DZ, Hazenbiller O, Gronlund T, et al. The AO spine RECODE-DCM international collaborative-establishing the foundations for accelerated and patient-centered innovation. Glob Spine J 2022;12:159S–71S.
- Behrbalk E, Salame K, Regev GJ, Keynan O, Boszczyk B, Lidar Z. Delayed diagnosis of cervical spondylotic myelopathy by primary care physicians. Neurosurg Focus 2013;35:E1.
- Mowforth OD, Davies BM, Kotter MR. ‘I am not delusional!’ Sensory dysaesthesia secondary to degenerative cervical myelopathy. BMJ Case Rep 2019;12:e229033.
- Cates JR, Soriano MM. Cervical spondylotic myelopathy. J Manipulative Physiol Ther 1995;18:471–5.
- Radcliff KE, Curry EP, Trimba R, et al. High incidence of undiagnosed cervical myelopathy in patients with hip fracture compared with controls. J Orthop Trauma 2016;30:189–93.
- Hilton B, Tempest-Mitchell J, Davies B, Kotter M. Route to diagnosis of degenerative cervical myelopathy in a UK healthcare system: a retrospective cohort study. BMJ Open 2019;9:e027000.
- Waqar M, Wilcock J, Garner J, Davies B, Kotter M. Quantitative analysis of medical students’ and physicians’ knowledge of degenerative cervical myelopathy. BMJ Open 2020;10:e028455.
- Mowforth O, Davies B, Stewart M, et al. Current provision of myelopathy education in medical schools in the UK: protocol for a national medical student survey. BMJ Open 2020;10:e035563.
- The Lancet Neurology Null. A focus on patient outcomes in cervical myelopathy. Lancet Neurol 2019;18:615.
- Artino AR, La Rochelle JS, Dezee KJ, Gehlbach H. Developing questionnaires for educational research: AMEE guide No. 87. Med Teach 2014;36:463–74.
- Roberts E. Elemental ideas: cervical spondylotic myelopathy. 2017. [Internet]. Available from: http://www.myelopathy.org/the-csm-documentary.html
- Davies BM, Mowforth OD, Khan DZ, et al. The development of lived experience-centered word clouds to support research uncertainty gathering in degenerative cervical myelopathy: results from an engagement process and protocol for their evaluation, via a nested randomized controlled trial. Trials 2021;22:415.
- Outcomes for graduates. 2021. [Internet]. [cited 2021 Dec 9]. Available from: https://www.gmc-uk.org/education/standards-guidance-and-curricula/standards-and-outcomes/outcomes-for-graduates/outcomes-for-graduates
- Oh T, Lafage R, Lafage V, et al. Comparing quality of life in cervical spondylotic myelopathy with other chronic debilitating diseases using the short form survey 36-health survey. World Neurosurg 2017;106:699–706.
- Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci U S A 2016;113:4296–301. 19
- Hoffmann DE, Tarzian AJ, The girl who cried pain: a bias against women in the treatment of pain. Rochester, NY: Social Science Research Network; 2001 [cited 2021 Dec 9]. Report No.: ID 383803. Available from: https://papers.ssrn.com/abstract=383803
- Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord 2009;23:306–14.
- Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci 2020;417:117054.
- Pellinen J, French J, Knupp KG. Diagnostic delay in epilepsy: the scope of the problem. Curr Neurol Neurosci Rep 2021;21:71.
- Oto M. (Meritxell). The misdiagnosis of epilepsy: appraising risks and managing uncertainty. Seizure - Eur J Epilepsy 2017;44:143–6.
- Falcão de Campos C, Gromicho M, Uysal H, et al. Delayed diagnosis and diagnostic pathway of ALS patients in Portugal: where can we improve? Front Neurol 2021;12:761355.
- Jozefowicz RF. Neurophobia: the fear of neurology among medical students. Arch Neurol 1994;51:328–9.
- Flanagan E, Walsh C, Tubridy N. ‘Neurophobia’– attitudes of medical students and doctors in Ireland to neurological teaching. Eur J Neurol 2007;14:1109–12.
- Abushouk AI, Duc NM. Curing neurophobia in medical schools: evidence-based strategies. Med Educ Online 2016;21:32476.
- McCarron M. 034 A systematic review of neurology education interventions. J Neurol Neurosurg Psychiatry 2012;83:e1–e1.
- Kruger J, Dunning D. Unskilled and unaware of it: how difficulties in recognizing one’s own incompetence lead to inflated self-assessments. J Pers Soc Psychol 1999;77:1121–34.
- Gallagher RM, Alam R, Shah S, Mueller L, Rogers JJ. Headache in medical education: medical schools, neurology and family practice residencies. Headache 2005;45:866–73.
- Pace A, Orr SL, Rosen NL, Safdieh JE, Cruz GB, Sprouse-Blum AS. The current state of headache medicine education in the United States and Canada: an observational, survey-based study of neurology clerkship directors and curriculum deans. Headache 2021;61:854–62.